Technavio has been monitoring the
Catheter Stabilization Device Market and our latest report shows that the market size is expected to reach a value of USD 710.81 million during 2021-2025 at an accelerating CAGR of 9.84% The emerging economies such as India and China are expected to provide a wide range of growth opportunities for top players in the market which is driven by growing incidences of heart and other lifestyle diseases.
Technavio has announced its latest market research report titled Catheter Stabilization Device Market by Application and Geography - Forecast and Analysis 2021-2025
Get a Free Sample Report for insights on the latest trends and challenges that will have an immense reaching effect on the market growth today!
BioDerm Announces New Vice President of Sales and Marketing
Florida-based manufacturing company, BioDerm, is proud to announce Jake Snee as a vital new addition to their team
News provided by
Share this article
Share this article
LARGO, Fla., March 2, 2021 /PRNewswire/ Jake Snee is joining BioDerm as their new Vice President of Sales and Marketing. Snee brings over fifteen years of Healthcare sales experience to his new position.
Snee, a Pennsylvania native, is a graduate of the Indiana University of Pennsylvania and launched his medical sales career as a Regional Business Director for an Augusta, Georgia Based Company, with a focus on men s health in urology. He continued to strengthen his career by launching a start-up company that created a product portfolio serving urological patients suffering from erectile dysfunction and urinary incontinence in the US.
(Separate multiple addresses with a comma)
Your Email Address
Your Message (optional)
Abacus Finance Provides $26.3MM in Debt Financing to Support Mountaingate Capitalâs LBO of BioDerm
January 19, 2021, 08:00 AM
In the first in transaction of its ten-year anniversary, Abacus Finance Group announced that it served as Senior Secured Credit Facilities Administrative Agent and Lead Arranger for $26.3 million in senior secured credit facilities to support the leveraged buyout of BioDerm, Inc. by Mountaingate Capital. Abacus â a leading provider of cash flow-based, classic senior debt for sponsor-led buyouts of companies with $3 million to $15 million in EBITDA â also made an equity co-investment in BioDerm.
Mountaingate Capital has made an investment in BioDerm Inc, a provider of disposable medical devices and wound care supplies to patients with chronic conditions.